Cro Dermatology

Full-Service Dermatology CRO

Innovaderm shares your mission of developing innovative treatments for patients living with skin diseases. With in-depth therapeutic expertise and our focus on dermatology, we are committed to the clinical development of the next generation of dermatology therapies. We provide comprehensive, full-service contract research organization solutions ranging from single to multicenter clinical trials. By partnering with Innovaderm, you make the choice to collaborate with a human-sized, agile and responsive company.

Discover our CRO solutions

Participate in a study

Do you have a skin condition? Would you like to contribute to the advancement of research? Innovaderm is committed to providing you with the best care during this journey. In exchange for your participation, you will be entitled to some financial compensation. Search for available studies now.

See available studies

UNEQUALLED SCIENTIFIC
EXPERTISE

IN-DEPTH THERAPEUTIC
KNOWLEDGE

INNOVATIVE PATIENT
RECRUITMENT

CLOSE SITE
RELATIONSHIP AND STRONG KOL NETWORK

Testimonial: Study Management During the Covid-19 Crisis

"Couldn’t be prouder of this team’s collective efforts in changing the course of this program in such a short amount of time. Superb guys! My hats off to all of you. Every day, I see your passion, your commitment, your sense of urgency, your drive to push this boulder up this mountain (with a smile) and I am so honoured to call you my teammates. You are also the most humblest team that I have worked for… never asking for praise or appreciation but doing your duty to the best of your ability. I couldn’t have asked for more."

-Director of Clinical Operations, Biotechnology Company

Dependable

Driven by Science

Dermatology Focused CRO

Testimonial: Study Management During the Covid-19 Crisis

"I want to express our heartfelt and sincere gratitude for the important and amazing work you continue to carry out for our company. The impact of the effort in which you are engaged helps maintain our business and cannot be overstated: together we are affecting the lives of patients with serious diseases. In some cases, these patients’ diseases are life threatening and they are counting on the experimental medicines that we are developing together. These are not normal times and it takes extra effort, planning, and execution to generate the drug product, pre-clinical information, or clinical data necessary to advance our important programs. We thank you for your extraordinary effort."

-Founder & CEO, Biotechnology Company